Private lending opportunity in the pharma distribution sector in Italy

A private lending opportunity (potentially secured), suitable for investors such as private credit funds, family offices, HNWIs, etc., offering a particularly attractive risk/return profile (10%+).

The transaction involves Q-Farma, an Italian group that has recently completed a consolidation phase, establishing itself as the leading operator in its sector in Italy (pharmaceutical distribution). While the group has a relatively high level of indebtedness, it operates in a sector characterized by structurally low risk and a sound medium-term debt sustainability profile. As part of a recent debt restructuring process that has now been completed, banks have rescheduled the medium-term facilities and confirmed the short-term lines, thereby ensuring continued support from the financial system.

The company is currently seeking new financing to support strategic investments planned for 2026 (approximately EUR 20 million), in a context where the domestic banking system is already significantly exposed.

The investment can be structured in different tranches (and therefore among multiple lenders). There is the possibility to create a lien over the financed assets. Gross return >10%; this particularly attractive return is driven by the group’s specific situation (the consolidation of two entities to create the market leader, with a high overall level of debt).

Teaser available upon request